MindBio Therapeutics Corp. — Proxy Solicitation & Information Statement 2024

Dec 12, 2024

MindBio Therapeutics

NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS

NOTICE IS HEREBY GIVEN that the annual general meeting (the “Meeting”) of the holders of common shares (“Shareholders”) of MindBio Therapeutics Corp. (the “Company”) will be held at Suite 2200, 885 West Georgia Street, Vancouver, British Columbia, Canada on the 18th day of December, 2024 at 2:00 p.m. (Vancouver time) for the following purposes:

(a) to receive the audited consolidated financial statements of the Company as at and for the financial year ended June 30, 2024 and 2023, together with the reports of the auditor thereon;
(b) to appoint MNP LLP as auditor of the Company for the ensuing year and authorize the board of directors to fix the remuneration of the auditor;
(c) to fix the number of the directors of the Company for the ensuing year at three (3);
(d) to elect directors to hold office for the ensuing year; and
(e) to transact such other business as may properly be transacted at the Meeting or at any adjournment thereof.

The specific details of the foregoing matters to be put before the Meeting, as well as further information with respect to voting by proxy, are set forth in the information circular accompanying this notice of Meeting. Only Shareholders of record at the close of business on November 5, 2024 are entitled to receive notice of and to vote at the Meeting.

A Shareholder who is unable to attend the Meeting in person and who wishes to ensure that such Shareholder’s shares will be voted at the Meeting is requested to complete, date and sign the enclosed form of proxy and deliver it in accordance with the instructions set out in the form of proxy and in the information circular accompanying this notice of Meeting.

The enclosed proxy is solicited by management, but you may amend it, if you so desire, by striking out the names listed therein and inserting in the space provided, the name of the person you wish to represent you at the Meeting.

DATED this 5th day of November, 2024.

By order of the Board of Directors

MINDBIO THERAPEUTICS CORP.

/s/ “Justin Hanka”

Justin Hanka
Chief Executive Officer